HomeIndustriesHealthcareOverlooked Stock: PTGX

Overlooked Stock: PTGX

Protagonist Therapeutics (PTGX) rallied 45% after its latest drug trial to treat people with active ulcerative colitis saw success. George Tsilis says there's more positive catalysts behind the stock, particularly its cash pile.

Market On Close

10 Mar 2025

SHARE

ON AIR
education
10:00 pm
Inside the Mind of a Trader
replay
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
7:00 am
Morning Movers
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Gamma On
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
ON AIR
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Schwab Network's Newsletters

Daily insights for every investor